It was reported that immune cell-derived IL-17 regulates stem cell features of pancreatic cancer cells by increasing the embryonic stem cell markers doublecortin-like kinase 1 (DCLK1) and ALDH 1 family member A1 (ALDH1A1) [98]. Here, DCLK1 is linked to pancreatic neoplasm.